September 22, 2025

Addition of Sintilimab to Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer

In a Chinese single-center phase II trial (SPRING-01) reported in The Lancet Oncology, Tian et al found that the addition of the PD-1 inhibitor sintilimab to chemotherapy following short-course radiot...

The ASCO Post

September 05, 2025

Can GLP-1s Double Colorectal Cancer Risk?

More than 5 million patients were included across seven retrospective studies.

Conexiant

January 01, 0001

Biomarkers in Colorectal Cancer: Implications for Nursing Practice

Despite a slight decrease in colorectal cancer cases in recent years, advancements in biomarker research are crucial for better patient outcomes. Source: American Cancer Society.

JADPRO

January 01, 0001

Rectal Cancer Incidence: Trends in Younger Patients

The latest cancer statistics unveil a promising decline in overall cancer rates, but an alarming rise in rectal cancer among younger adults requires urgent attention from healthcare professionals. Source: ACS.

JADPRO

January 01, 0001

Reports from the 2010 ASCO Annual Meeting

Explore groundbreaking findings from the 2010 ASCO meeting, highlighting shifts in treatment strategies for glioblastoma and colorectal cancer.

JADPRO

January 02, 2025

FDA Approves Nivolumab and Hyaluronidase-nvhy for Subcutaneous Injection

On December 27, 2024, the U.S. Food and Drug Administration approved nivolumab and hyaluronidase-nvhy (Opdivo Qvantig) for subcutaneous injection across approved adult, solid tumor nivolumab indicatio...

The ASCO Post

August 02, 2023

Gastrointestinal Symptoms May Be Prevalent in Geriatric Female Colorectal Cancer Survivors

About 80% of geriatric female colorectal cancer survivors may experience a range of gastrointestinal symptoms years after receiving a diagnosis and treatment for their tumors, according to a recent st...

The ASCO Post

December 04, 2023

Consuming Navy Beans May Improve Gut Health, Regulate Immune and Inflammatory Processes in Colorectal Cancer Survivors

Researchers investigated whether the regular consumption of navy beans could help improve the gut microbiome of colorectal cancer survivors.

The ASCO Post

November 13, 2023

FDA Approves Fruquintinib for Refractory Metastatic Colorectal Cancer

On November 8, the FDA approved an anti-VEGF tyrosine kinase inhibitor for adult patients with metastatic colorectal cancer who received prior fluoropyrimidine-, oxaliplatin-, and irinotecan-based che...

The ASCO Post